Previous studies using plasma cortisol estimations have suggested that hypo
thalmo-pituitary-axis (HPA) activation occurs in alcohol-dependent patients
during alcohol withdrawal. The present study set out to confirm this findi
ng using salivary cortisol assays, which are a better indicator of plasma f
ree cortisol, the fraction which exerts its physiological effects. Nine alc
ohol dependent patients provided four saliva samples (at 10 a.m., 2 p.m., 6
p.m. and 10 p.m.) on days 1, 3 and 7 of a medically assisted alcohol withd
rawal (corresponding to 1, 3 and 7 days following the last drink, respectiv
ely). Withdrawal symptom severity, craving and mood disturbance were also m
easured. A group of non-alcohol-dependent individuals, without psychiatric
or medical disorder, gave four samples at the same times on one day only. M
ean daily cortisol levels in our alcohol-dependent population, as calculate
d by the area under the cur ve (AUC), decreased significantly over time (me
an AUC (nmol/l/hour) on day 1 = 149, on day 7 = 85.7, p = 0.009) and were s
ignificantly higher than controls on each day (mean AUC in controls = 28.3,
p = 0.001). The cortisol response showed a similar temporal trend to withd
rawal symptom severity and mood disturbance. This is consistent with previo
us studies measuring plasma cortisol in alcohol withdrawal. However, the ma
gnitude of the effect in our study was greater, and in contrast to some pre
vious studies, levels were far from normal by day 7. The comparatively low
cortisol response in our one mildly dependent patient suggests that there m
ay be a relationship between dependence severity and the size of the cortis
ol response to withdrawal. Salivary cortisol sampling could prove to be a u
seful prognostic tool, with implications for subsequent withdrawal symptom
severity, mood disturbances, risk of relapse and alcohol-related cognitive
decline. There are implications for developing new treatments for alcohol w
ithdrawal but more studies are needed.